EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anti-inflammatory effect of nestorone in a lipopolysaccharide-induced acute lung injury model through regulation of the TLR-4/Myd88/NF-κB signaling pathway

Aying Ma, Jieyun Zhou, Hui Zou, Li Yuan, Ruihua Zhong, Yan Zhu, Chao Gao

Inflammopharmacology · 2025-03 · 33 (3) · 1473-1489

DOI: 10.1007/s10787-024-01625-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammopharmacology, online erschienen am 17.12.2024. Verfasst von Aying Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery and Transplantation and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institu…. Hauptthemen laut MEDLINE: Acute Lung Injury, Toll-Like Receptor 4, Anti-Inflammatory Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Youth Foundation of Zhongshan Hospital Fudan University, National Key Research and Development Program of China, Natural Science Foundation of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progesterone plays a crucial and indispensable role in regulating immunity and attenuating inflammation. Nestorone® (NES, segesterone acetate) is a steroidal progestin and a 19-norprogesterone derivative with no -CH3 group radical at the 6-position. Here, we showed that NES enhanced the viability of lipopolysaccharide (LPS)-stimulated THP-1 cell-derived macrophages, potently inhibiting both arms of the Toll-like receptor 4 (TLR-4) signaling cascade triggered by LPS, especially the TLR-4/MyD88/NF-κB pathway. In addition, NES exerted an anti-inflammatory effect by significantly decreasing the secretion of inflammatory cytokines and chemokines in type II alveolar epithelial A549 cells and THP-1 cell-derived macrophages stimulated by LPS. Furthermore, we evaluated the potential of NES pre-treatment, administered 2 h prior to LPS exposure, to mitigate acute lung injury induced by LPS, using an LPS-induced acute lung injury (ALI) mouse model. In this study, NES alleviated lung inflammation and damage by reducing leukocyte infiltration and inflammatory cytokines in the bronchoalveolar lavage fluid (BALF) and lung tissues of mice. Interestingly, our findings indicate that NES at a dosage of 1 mg/kg (91.67%) was more effective than at dosages of 0.1 mg/kg (70.83%) or 10 mg/kg (87.50%), as well as more effective than dexamethasone (DEX, 5 mg/kg, 83.34%), in extending survival in mice subjected to lethal LPS-induced injury. Additionally, this dosage was more successful in reducing acute lung inflammation and alleviating diffuse alveolar damage in the lungs of C57 mice. Our study indicates that concentration is a critical determinant of the anti-inflammatory efficacy of NES. Consequently, NES emerges as a potentially promising therapeutic agent for the treatment of pulmonary inflammatory conditions through the modulation of TLR-4 signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryToll-Like Receptor 4Anti-Inflammatory AgentsAnimalsLipopolysaccharidesMiceNF-kappa BSignal TransductionHumansMyeloid Differentiation Factor 88Disease Models, AnimalA549 CellsMaleMice, Inbred C57BLMacrophagesCytokinesTHP-1 CellsInflammation

Stichwörter der Autor:innen

A549Acute lung injuryAnti-inflammatoryNestoroneReporter cellToll-like receptor

Substanzen

LipopolysaccharidesToll-Like Receptor 4Anti-Inflammatory AgentsNF-kappa BMyeloid Differentiation Factor 88Cytokines

Autor:innen und Institutionen

  • Department of Liver Surgery and Transplantation and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • NHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, 200032, China.
  • Department of Gastroenterology, Jingdezhen Hospital of Traditional Chinese Medicine, Jingdezhen, 333000, China.
  • NHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, 200032, China. zhuyan@si…
  • Department of Liver Surgery and Transplantation and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. gao…

Förderung

  • Youth Foundation of Zhongshan Hospital Fudan University
  • National Key Research and Development Program of China
  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Ma, A., Zhou, J., Zou, H., Yuan, L., Zhong, R., Zhu, Y., & Gao, C. (2025). Anti-inflammatory effect of nestorone in a lipopolysaccharide-induced acute lung injury model through regulation of the TLR-4/Myd88/NF-κB signaling pathway. Inflammopharmacology, 33(3), 1473-1489. https://doi.org/10.1007/s10787-024-01625-6

Vancouver

Ma A, Zhou J, Zou H, Yuan L, Zhong R, Zhu Y, et al. Anti-inflammatory effect of nestorone in a lipopolysaccharide-induced acute lung injury model through regulation of the TLR-4/Myd88/NF-κB signaling pathway. Inflammopharmacology. 2025;33(3):1473-1489. doi:10.1007/s10787-024-01625-6

BibTeX
@article{Ma2025,
  author = {Ma, Aying and Zhou, Jieyun and Zou, Hui and Yuan, Li and Zhong, Ruihua and Zhu, Yan and Gao, Chao},
  title = {Anti-inflammatory effect of nestorone in a lipopolysaccharide-induced acute lung injury model through regulation of the TLR-4/Myd88/NF-κB signaling pathway},
  journal = {Inflammopharmacology},
  year = {2025},
  volume = {33},
  number = {3},
  pages = {1473--1489},
  doi = {10.1007/s10787-024-01625-6}
}
Kostenlos starten →